Keywords
How to Cite
Abstract
Pneumoconioses are occupational lung diseases associated with the inhalation of inorganic dusts, with varying prevalence worldwide, especially in industries with inadequate regulations. Despite improvements in developed countries, pneumoconiosis incidence remains and is increasing in emerging sectors like artificial stone production and handling. These diseases pose a significant global public health risk, especially in regions with limited workplace controls. We propose an International Pneumoconiosis Observatory to monitor prevalence and incidence, assess preventive measures, and coordinate international regulations. This entity would enable preventive strategy development, knowledge exchange, and rapid responses to new exposure risks. A coordinated global effort is essential to curbing pneumoconiosis cases and protecting vulnerable workers.
References
Hoy RF, Jeebhay MF, Cavalin C, Chen W, Cohen RA, Fireman E, et al. Current global perspectives on silicosis: Convergence of old and newly emergent hazards. Respirology. 2022;27(6):387-398. doi: 10.1111/resp.14242.
Cohen RA, Go LHT, Rose CS. Global Trends in Occupational Lung Disease. Semin Respir Crit Care Med. 2023;44(3):317-326.
Comité Mixto OIT/OMS sobre Salud Ocupacional. Directrices técnicas y éticas para la vigilancia de la salud de los trabajadores. Ginebra: Organización Internacional del Trabajo; 1995. Disponible en: https://www.ilo.org/global/topics/safety-and-health-at-work/lang--es/index.htm.
Organización Internacional del Trabajo, Organización Mundial de la Salud. Programa Mundial para la Eliminación de la Silicosis (GPES). Ginebra: OIT/OMS; 2005. Disponible en: https://www.ilo.org.
Organización Mundial de la Salud. Estimaciones conjuntas OMS/OIT de la carga de enfermedades y lesiones relacionada con el trabajo, 2000-2016: informe de vigilancia mundial. Actualizado 17 de septiembre de 2021. Disponible en: https://www.who.int/teams/environment-climate-change-and-health/monitoring/who-ilo-joint-estimates.
Krefft S, Wolff J, Rose C. Silicosis: An Update and Guide for Clinicians. Clin Chest Med. 2020 Dec;41(4):709-722.E.
EU-OSHA. Enfermedades relacionadas con el trabajo. Disponible en: https://osha.europa.eu/en/themes/work-related-diseases.
International Agency for Research on Cancer. Arsenic, metals, fibres, and dusts. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Vol. 100C. Lyon (France): IARC; 2012. Pp. 210-309.
Ao LH, Wei YG, Tian HR, Zhao H, Li J, Ban JQ. Advances in the study of silica nanoparticles in lung diseases. Sci Total Environ. 2024;912:169352.
Lv S, Li Y, Li X, Zhu L, Zhu Y, Guo C, Li Y. Silica nanoparticles triggered epithelial ferroptosis via miR-21-5p/GCLM signaling to contribute to fibrogenesis in the lungs. Chem Biol Interact. 2024;399:111121.
Wagner JC, Sleggs CA, Marchand P. Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province. Br J Ind Med. 1960;17(4):260-271.
Klebe S, Rathi V, Russell PA. Lung cancer caused by asbestos: What a reporting pathologist needs to know. Lung Cancer. 2024;195:107849.
Schlünssen V, Mandrioli D, Pega F, Momen NC, Ádám B, Chen W, et al. The prevalences and levels of occupational exposure to dusts and/or fibres (silica, asbestos and coal): A systematic review and meta-analysis from the WHO/ILO Joint Estimates of the Work-related Burden of Disease and Injury. Environ Int. 2023;178:107980.
International Ban Asbestos Secretariat. Disponible en: http://www.ibasecretariat.org/graphics_page.php http://www.ibasecretariat.org/.
Da Silva e Silva A, Maia M. El STF y el uso del amianto en Brasil: un estudio de caso de las ADIs N. 3.937/SP E N. 4.066/DF. Veredas do Direito. 2021;18:255-278.
Carga Global de la Enfermedad 2021: Hallazgos del Estudio GBD 2021. Disponible en: https://www.healthdata.org/research-analysis/gbd.
Martinez C, Prieto A, Garcia L, Quero A, Gonzalez S, Casan P. Silicosis: a disease with an active present. Arch Bronconeumol. 2010;46(2):97-100.
Hoy RF, Baird T, Hammerschlag G, Hart D, Johnson AR. Artificial stone-associated silicosis: A rapidly emerging occupational lung disease. J Occup Health. 2021;63(1):e12228. doi: 10.1002/1348-9585.12228.
León-Jiménez A. New Etiological Agents of Silicosis. Arch Bronconeumol. 2023;59(8):479-480.
Di Benedetto F, Giaccherini A, Montegrossi G, et al. Chemical variability of artificial stone powders in relation to their health effects. Sci Rep. 2019;9(1):6531. doi: 10.1038/s41598-019-42238-2.
León-Jiménez A, Hidalgo-Molina A, Conde-Sánchez MÁ, Pérez-Alonso A, Morales-Morales JM, García-Gámez EM, Córdoba-Doña JA. Artificial Stone Silicosis: Rapid Progression Following Exposure Cessation. Chest. 2020;158(3):1060-1068.
León-Jiménez A, Mánuel JM, García-Rojo M, et al. Compositional and structural analysis of engineered stones and inorganic particles in silicotic nodules of exposed workers. Part Fibre Toxicol. 2021;18(1):41. doi: 10.1186/s12989-021-00421-5.
Menéndez-Navarro A, Cavalin C, García-Gómez M, Gherasim A. La remergencia de la silicosis como enfermedad profesional en España, 1990-2019. Rev Esp Salud Publica. 2021;95:e202108106.
Kirby T. Australia bans engineered stone to prevent silicosis. Lancet Respir Med. 2024;12:e18.
Hua JT, Zell-Baran L, Go LHT, et al. Demographic, exposure and clinical characteristics in a multinational registry of engineered stone workers with silicosis. Occup Environ Med. 2022;79(9):586-593.
García López V, Jové Gómez D, Marin Martinez B, Chocrón Miño S, Castillo Sabogal A, Ibarra García A. Enfermedad pulmonar intersticial difusa de posible origen laboral atendida en el Servicio Navarro de Salud. Navarra, Arch Prev Riesgos Labor. 2024;27(2):173-189.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright (c) 2025 Anselmo López- Guillén , Antonio León-Jiménez, Diemen Delgado-García, Alan López-López